Korean male active smokers: quantifying their smoking habits and the transformation factor among biomarkers in urine and blood

References

• Benowitz, N.L., et al., 2003. Nicotine metabolite ratio as a predictor of cigarette consumption. Nicotine & tobacco research: official journal of the society for research on nicotine and tobacco, 5 (5), 621–624.
   PubMed Web of Science ®Google Scholar
• Benowitz, N. L., Hukkanen, J., and Jacob, P., 2009. Nicotine chemistry, metabolism, kinetics and biomarkers. In: J.E. Henningfield, E.D. London, S. Pogun, eds. Handbook of experimental pharmacology. Berlin: Springer, 29–60.
   Google Scholar
• Carmella, S.G., et al., 2005. Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in smokers' blood. Cancer epidemiology, biomarkers & prevention : a publication of the american association for cancer research, cosponsored by the american society of preventive oncology, 14 (11 Pt 1), 2669–2672.
   PubMed Web of Science ®Google Scholar
• Chung, S., et al., 2015. Smoking topography in Korean American and White Men: preliminary findings. Journal of immigrant and minority health, 17 (3), 860–866.
   PubMed Web of Science ®Google Scholar
• Dempsey, D., et al., 2004. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clinical pharmacology and therapeutics, 76 (1), 64–72.
   PubMed Web of Science ®Google Scholar
• Fagerstrom, K.O. and Schneider, N.G., 1989. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. Journal of behavioral medicine, 12 (2), 159–182.
   PubMed Web of Science ®Google Scholar
• Fix, B.V., et al., 2017. Nicotine Metabolite Ratio (NMR) prospectively predicts smoking relapse: longitudinal findings from ITC surveys in five countries. Nicotine & tobacco research, 19 (9), 1040–1047.
   PubMed Web of Science ®Google Scholar
• Gold, A.B. and Lerman, C., 2012. Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. Human genetics, 131 (6), 857–876.
   Web of Science ®Google Scholar
• Golechha, M., 2016. Health promotion methods for smoking prevention and cessation: a comprehensive review of effectiveness and the way forward. International journal of preventive medicine, 7, 7.
   PubMed Web of Science ®Google Scholar
• Gunter, R., et al., 2020. Cigarette smoking in South Korea: a narrative review. Korean journal of family medicine, 41 (1), 3–13.
   PubMed Web of Science ®Google Scholar
• Hamilton, D.A., et al., 2015. Test-retest reliability and stability of the nicotine metabolite ratio among treatment-seeking smokers. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco , 17 (12), 1505–1509.
   PubMed Web of Science ®Google Scholar
• Jacob, P., et al., 2011. Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity. Journal of chromatography. B, analytical technologies in the biomedical and life sciences, 879 (3-4), 267–276.
   PubMed Web of Science ®Google Scholar
• Jha, P., et al., 2013. 21st-century hazards of smoking and benefits of cessation in the United States. The new England journal of medicine, 368 (4), 341–350.
   PubMed Web of Science ®Google Scholar
• Jung, S., et al., 2012. Urine cotinine for assessing tobacco smoke exposure in Korean: analysis of the Korea National Health and Nutrition Examination Survey (KNHANES). Tuberculosis and respiratory diseases, 73 (4), 210–218.
   PubMedGoogle Scholar
• Kandel, D.B., et al., 2007. Urine nicotine metabolites and smoking behavior in a multiracial/multiethnic national sample of young adults. American journal of epidemiology, 165 (8), 901–910.
   PubMed Web of Science ®Google Scholar
• Kim, S. and Yu, S., 2018. Smoking topography among Korean smokers: intensive smoking behavior with larger puff volume and shorter interpuff interval. International journal of environmental research and public health, 15 (5), 1024.
   Web of Science ®Google Scholar
• Korea Centers for Disease Control and Prevention. 2018. The Seventh Korea National Health and Nutrition Examination Survey (KNHANES VII-2) [online]. Available from: http://knhanes.cdc.go.kr/knhanes [Accessed 9 February 2020].
   Google Scholar
• Lerman, C., et al., 2006. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clinical pharmacology & therapeutics, 79 (6), 600–608.
   PubMed Web of Science ®Google Scholar
• Levi, M., et al., 2007. Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model application. Journal of pharmacokinetics and pharmacodynamics, 34 (1), 23–34.
   PubMed Web of Science ®Google Scholar
• Liakoni, E., et al., 2019. Effects of nicotine metabolic rate on withdrawal symptoms and response to cigarette smoking after abstinence. Clinical pharmacology & therapeutics, 105 (3), 641–651.
   PubMed Web of Science ®Google Scholar
• Patrick, H., et al., 2018. A comprehensive digital program for smoking cessation: assessing feasibility in a single-group cohort study. JMIR mHealth and uhealth, 6 (12), e11708.
   PubMed Web of Science ®Google Scholar
• Peters, S.A.E., Huxley, R.R., and Woodward, M., 2014. Do smoking habits differ between women and men in contemporary Western populations? Evidence from half a million people in the UK Biobank study. BMJ open, 4 (12), e005663.
   PubMed Web of Science ®Google Scholar
• Schnoll, R.A., et al., 2014. The relationship between the nicotine metabolite ratio and three self-report measures of nicotine dependence across sex and race. Psychopharmacology, 231 (12), 2515–2523.
   PubMed Web of Science ®Google Scholar
• Shahab, L., et al., 2017. Characterising the nicotine metabolite ratio and its association with treatment choice: a cross sectional analysis of Stop Smoking Services in England. Scientific reports, 7 (1), 17613.
   PubMedGoogle Scholar
• Shaik, S.S., et al., 2016. Tobacco use cessation and prevention – a review. Journal of clinical and diagnostic research : JCDR, 10 (5), ZE13–ZE17.
   PubMed Web of Science ®Google Scholar
• St. Helen, G., et al., 2012. Reproducibility of the nicotine metabolite ratio in cigarette smokers. Cancer epidemiology, biomarkers & prevention : a publication of the american association for cancer research, cosponsored by the american society of preventive oncology, 21 (7), 1105–1114.
   PubMed Web of Science ®Google Scholar
• St. Helen, G., Jacob, P., and Benowitz, N.L., 2013. Stability of the nicotine metabolite ratio in smokers of progressively reduced nicotine content cigarettes. Nicotine & tobacco research : official journal of the society for research on nicotine and tobacco, 15 (11), 1939–1942.
   PubMed Web of Science ®Google Scholar
• Strasser, A.A., et al., 2011. Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level. Cancer epidemiology, biomarkers & prevention : a publication of the american association for cancer research, cosponsored by the american society of preventive oncology, 20 (2), 234–238.
   PubMed Web of Science ®Google Scholar
• Thompson, S.G., et al., 1990. How should urinary cotinine concentrations be adjusted for urinary creatinine concentration? Clinica chimica acta, 187 (3), 289–295.
   PubMed Web of Science ®Google Scholar
• Torres, S., et al., 2018. Biomarkers of exposure to secondhand and thirdhand tobacco smoke: recent advances and future perspectives. International journal of environmental research and public health, 15 (12), 2693.
   Web of Science ®Google Scholar
• West, O., Hajek, P., and McRobbie, H., 2011. Systematic review of the relationship between the 3-hydroxycotinine/cotinine ratio and cigarette dependence. Psychopharmacology, 218 (2), 313–322.
   PubMed Web of Science ®Google Scholar
• World Health Organization, 2019. WHO Report on The Global Tobacco Epidemic: offer to help quit tobacco use.
   Google Scholar
• Xia, Y., et al., 2005. Analysis of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanol in urine by extraction on a molecularly imprinted polymer column and liquid chromatography/atmospheric pressure ionisation tandem mass spectrometry. Analytical chemistry, 77 (23), 7639–7645.
   PubMed Web of Science ®Google Scholar
• Xia, Y., et al., 2011. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the united states: NHANES 2007–2008. Biomarkers, 16 (2), 112–119.
   PubMed Web of Science ®Google Scholar
• Yuan, J.M., et al., 2014. Urinary tobacco smoke-constituent biomarkers for assessing risk of lung cancer. Cancer research, 74 (2), 401–411.
   PubMed Web of Science ®Google Scholar
• Zhu, S.H., et al., 2012. Interventions to increase smoking cessation at the population level: how much progress has been made in the last two decades? Tobacco control, 21 (2), 110–118.
   PubMed Web of Science ®Google Scholar